TreeWAS – Variant ID: rs2460504

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.073	0.927	0.000
L02 Cutaneous abscess, furuncle and carbuncle	0.055	0.945	0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.049	0.951	0.000
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.047	0.953	0.000
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites	0.046	0.954	0.000
L02.0 Cutaneous abscess, furuncle and carbuncle of face	0.045	0.955	0.000
T42.4 Benzodiazepines	0.035	0.965	0.000
N75.1 Abscess of Bartholin's gland	0.033	0.967	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.031	0.969	0.000
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.028	0.972	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.026	0.974	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.026	0.974	0.000
T42.1 Iminostilbenes	0.023	0.977	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.022	0.978	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.022	0.978	0.000
T42.3 Barbiturates	0.022	0.978	0.000
T42.2 Succinimides and oxazolidinediones	0.022	0.978	0.000
T42.0 Hydantoin derivatives	0.022	0.978	0.000
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.022	0.978	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.020	0.980	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.018	0.982	0.000
T39.0 Salicylates	0.017	0.983	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.017	0.983	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.017	0.983	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.016	0.983	0.000
Z53.2 Procedure not carried out because of patient's decision for other and unspecified reasons	0.000	0.984	0.016
T36 Poisoning by systemic antibiotics	0.016	0.984	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.016	0.984	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.015	0.985	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.015	0.985	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.015	0.985	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.015	0.985	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.014	0.986	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.014	0.986	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.014	0.986	0.000
T48.5 Anti-common-cold drugs	0.014	0.986	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.014	0.986	0.000
T36.0 Penicillins	0.013	0.986	0.000
T50.4 Drugs affecting uric acid metabolism	0.013	0.987	0.000
T50.8 Diagnostic agents	0.013	0.987	0.000
T50.7 Analeptics and opioid receptor antagonists	0.013	0.987	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.013	0.987	0.000
T50.5 Appetite depressants	0.013	0.987	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.013	0.987	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.013	0.987	0.000
T50.1 Loop [high-ceiling] diuretics	0.013	0.987	0.000
T50.0 Mineralocorticoids and their antagonists	0.013	0.987	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.013	0.987	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.013	0.987	0.000
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.000	0.987	0.013
T48.6 Antiasthmatics, not elsewhere classified	0.012	0.988	0.000
T40.4 Other synthetic narcotics	0.012	0.988	0.000
T39.4 Antirheumatics, not elsewhere classified	0.012	0.988	0.000
T39.2 Pyrazolone derivatives	0.012	0.988	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.012	0.988	0.000
T48.4 Expectorants	0.012	0.988	0.000
T48.3 Antitussives	0.012	0.988	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.012	0.988	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.012	0.988	0.000
T48.0 Oxytocic drugs	0.012	0.988	0.000
T36.9 Systemic antibiotic, unspecified	0.012	0.988	0.000
T36.8 Other systemic antibiotics	0.012	0.988	0.000
T36.7 Antifungal antibiotics, systemically used	0.012	0.988	0.000
T36.6 Rifamycins	0.012	0.988	0.000
T36.5 Aminoglycosides	0.012	0.988	0.000
T36.4 Tetracyclines	0.012	0.988	0.000
T36.3 Macrolides	0.012	0.988	0.000
T36.2 Chloramphenicol group	0.012	0.988	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.012	0.988	0.000
T38.1 Thyroid hormones and substitutes	0.012	0.988	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.011	0.988	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.011	0.988	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.011	0.988	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.011	0.988	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.011	0.988	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.011	0.988	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.011	0.988	0.000
T44.0 Anticholinesterase agents	0.011	0.988	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.011	0.989	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.011	0.989	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.011	0.989	0.000
T37.5 Antiviral drugs	0.011	0.989	0.000
T37.4 Anthelminthics	0.011	0.989	0.000
T37.3 Other antiprotozoal drugs	0.011	0.989	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.011	0.989	0.000
T37.1 Antimycobacterial drugs	0.011	0.989	0.000
T37.0 Sulphonamides	0.011	0.989	0.000
T41.5 Therapeutic gases	0.011	0.989	0.000
T41.4 Anaesthetic, unspecified	0.011	0.989	0.000
T41.3 Local anaesthetics	0.011	0.989	0.000
T41.2 Other and unspecified general anaesthetics	0.011	0.989	0.000
T41.1 Intravenous anaesthetics	0.011	0.989	0.000
T41.0 Inhaled anaesthetics	0.011	0.989	0.000
T49.9 Topical agent, unspecified	0.011	0.989	0.000
T49.8 Other topical agents	0.011	0.989	0.000
T49.7 Dental drugs, topically applied	0.011	0.989	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.011	0.989	0.000
T49.5 Ophthalmological drugs and preparations	0.011	0.989	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.011	0.989	0.000
T49.3 Emollients, demulcents and protectants	0.011	0.989	0.000
T49.2 Local astringents and local detergents	0.011	0.989	0.000
T49.1 Antipruritics	0.011	0.989	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.011	0.989	0.000
T45.0 Antiallergic and antiemetic drugs	0.011	0.989	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.011	0.989	0.000
T40.2 Other opioids	0.011	0.989	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.011	0.989	0.000
T40.8 Lysergide [LSD]	0.011	0.989	0.000
T40.7 Cannabis (derivatives)	0.011	0.989	0.000
T40.5 Cocaine	0.011	0.989	0.000
T40.3 Methadone	0.011	0.989	0.000
T40.1 Heroin	0.011	0.989	0.000
T40.0 Opium	0.011	0.989	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.010	0.989	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.010	0.989	0.000
T47.7 Emetics	0.010	0.989	0.000
T47.6 Antidiarrhoeal drugs	0.010	0.989	0.000
T47.5 Digestants	0.010	0.989	0.000
T47.4 Other laxatives	0.010	0.989	0.000
T47.3 Saline and osmotic laxatives	0.010	0.989	0.000
T47.2 Stimulant laxatives	0.010	0.989	0.000
T47.0 Histamine H(2)-receptor antagonists	0.010	0.989	0.000
T38.9 Other and unspecified hormone antagonists	0.010	0.990	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.010	0.990	0.000
T38.7 Androgens and anabolic congeners	0.010	0.990	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.010	0.990	0.000
T38.5 Other oestrogens and progestogens	0.010	0.990	0.000
T38.4 Oral contraceptives	0.010	0.990	0.000
T38.2 Antithyroid drugs	0.010	0.990	0.000
T38.0 Glucocorticoids and synthetic analogues	0.010	0.990	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.010	0.990	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.010	0.990	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.010	0.990	0.000
T43.9 Psychotropic drug, unspecified	0.010	0.990	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.010	0.990	0.000
T43.2 Other and unspecified antidepressants	0.010	0.990	0.000
T45.2 Vitamins, not elsewhere classified	0.010	0.990	0.000
I69 Sequelae of cerebrovascular disease	0.000	0.990	0.010
T45.9 Primarily systemic and haematological agent, unspecified	0.009	0.990	0.000
T45.8 Other primarily systemic and haematological agents	0.009	0.990	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.009	0.990	0.000
T45.6 Fibrinolysis-affecting drugs	0.009	0.990	0.000
T45.4 Iron and its compounds	0.009	0.990	0.000
T45.3 Enzymes, not elsewhere classified	0.009	0.990	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.990	0.010
S02.10 Fracture of base of skull (closed)	0.000	0.991	0.009
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.991	0.009
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.991	0.009
E61.1 Iron deficiency	0.000	0.991	0.009
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.991	0.009
T43.4 Butyrophenone and thioxanthene neuroleptics	0.009	0.991	0.000
I69.3 Sequelae of cerebral infarction	0.000	0.991	0.009
T46 Poisoning by agents primarily affecting the cardiovascular system	0.008	0.991	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.992	0.008
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.008	0.992	0.000
N75 Diseases of Bartholin's gland	0.008	0.992	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.008	0.992	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.008	0.992	0.000
F20.0 Paranoid schizophrenia	0.008	0.992	0.000
T43.6 Psychostimulants with abuse potential	0.008	0.992	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.008	0.992	0.000
T39.1 4-Aminophenol derivatives	0.007	0.993	0.000
T40.6 Other and unspecified narcotics	0.007	0.993	0.000
S02.1 Fracture of base of skull	0.000	0.993	0.007
L00-L08 Infections of the skin and subcutaneous tissue	0.007	0.993	0.000
L90.5 Scar conditions and fibrosis of skin	0.000	0.993	0.007
C81.9 Hodgkin's disease, unspecified	0.007	0.993	0.000
T45.5 Anticoagulants	0.006	0.993	0.000
L04 Acute lymphadenitis	0.007	0.993	0.000
C81 Hodgkin's disease	0.006	0.994	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.006	0.994	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.006	0.994	0.000
T46.7 Peripheral vasodilators	0.006	0.994	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.006	0.994	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.006	0.994	0.000
F20 Schizophrenia	0.006	0.994	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.000	0.994	0.006
L01 Impetigo	0.006	0.994	0.000
S02 Fracture of skull and facial bones	0.000	0.994	0.006
N75.9 Disease of Bartholin's gland, unspecified	0.006	0.994	0.000
N75.8 Other diseases of Bartholin's gland	0.006	0.994	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.006	0.994	0.000
S02.8 Fractures of other skull and facial bones	0.000	0.994	0.006
F20.9 Schizophrenia, unspecified	0.006	0.994	0.000
T46.1 Calcium-channel blockers	0.006	0.994	0.000
C81.0 Lymphocytic predominance	0.006	0.994	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.994	0.006
T46.5 Other antihypertensive drugs, not elsewhere classified	0.006	0.994	0.000
L04.0 Acute lymphadenitis of face, head and neck	0.006	0.994	0.000
R93.8 Abnormal findings on diagnostic imaging of other specified body structures	0.000	0.994	0.006
O47.9 False labour, unspecified	0.006	0.994	0.000
C83.1 Small cleaved cell (diffuse)	0.006	0.994	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.006	0.994	0.000
S02.3 Fracture of orbital floor	0.000	0.994	0.006
T46.3 Coronary vasodilators, not elsewhere classified	0.006	0.994	0.000
S02.30 Fracture of orbital floor (closed)	0.000	0.994	0.006
L01.0 Impetigo [any organism] [any site]	0.006	0.994	0.000
S02.5 Fracture of tooth	0.000	0.994	0.006
L04.1 Acute lymphadenitis of trunk	0.005	0.994	0.000
L00 Staphylococcal scalded skin syndrome	0.005	0.994	0.000
C83.0 Small cell (diffuse)	0.005	0.995	0.000
S02.0 Fracture of vault of skull	0.000	0.995	0.005
E87.7 Fluid overload	0.005	0.995	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.005	0.995	0.000
C83.3 Large cell (diffuse)	0.005	0.995	0.000
S02.50 Fracture of tooth (closed)	0.000	0.995	0.005
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
S02.11 Fracture of base of skull (open)	0.000	0.995	0.005
D68.9 Coagulation defect, unspecified	0.000	0.995	0.005
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.005	0.995	0.000
L04.9 Acute lymphadenitis, unspecified	0.005	0.995	0.000
L04.8 Acute lymphadenitis of other sites	0.005	0.995	0.000
L04.3 Acute lymphadenitis of lower limb	0.005	0.995	0.000
L04.2 Acute lymphadenitis of upper limb	0.005	0.995	0.000
D68.8 Other specified coagulation defects	0.000	0.995	0.005
T46.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
D68 Other coagulation defects	0.000	0.995	0.005
F20.5 Residual schizophrenia	0.005	0.995	0.000
F33 Recurrent depressive disorder	0.005	0.995	0.000
S02.9 Fracture of skull and facial bones, part unspecified	0.000	0.995	0.005
M50.1 Cervical disk disorder with radiculopathy	0.005	0.995	0.000
C81.7 Other Hodgkin's disease	0.005	0.995	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.005	0.995	0.000
C81.3 Lymphocytic depletion	0.005	0.995	0.000
C84.4 Peripheral T-cell lymphoma	0.005	0.995	0.000
D68.6 Other Thrombophilia	0.000	0.995	0.005
F20.8 Other schizophrenia	0.005	0.995	0.000
F20.6 Simple schizophrenia	0.005	0.995	0.000
F20.4 Postschizophrenic depression	0.005	0.995	0.000
F20.3 Undifferentiated schizophrenia	0.005	0.995	0.000
F20.2 Catatonic schizophrenia	0.005	0.995	0.000
F20.1 Hebephrenic schizophrenia	0.005	0.995	0.000
S02.00 Fracture of vault of skull (closed)	0.000	0.995	0.005
S02.6 Fracture of mandible	0.000	0.995	0.005
C81.2 Mixed cellularity	0.005	0.995	0.000
C84.0 Mycosis fungoides	0.005	0.995	0.000
D68.2 Hereditary deficiency of other clotting factors	0.000	0.995	0.005
L01.1 Impetiginisation of other dermatoses	0.005	0.995	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.005	0.995	0.000
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.000	0.995	0.005
S02.7 Multiple fractures involving skull and facial bones	0.000	0.995	0.005
C83.6 Undifferentiated (diffuse)	0.005	0.995	0.000
C83.5 Lymphoblastic (diffuse)	0.005	0.995	0.000
C83.4 Immunoblastic (diffuse)	0.005	0.995	0.000
C83.2 Mixed small and large cell (diffuse)	0.005	0.995	0.000
S02.81 Fractures of other skull and facial bones (open)	0.000	0.995	0.005
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.995	0.005
C91.0 Acute lymphoblastic leukaemia	0.005	0.995	0.000
I24.8 Other forms of acute ischaemic heart disease	0.000	0.995	0.005
I24 Other acute ischaemic heart diseases	0.000	0.995	0.005
C91 Lymphoid leukaemia	0.005	0.995	0.000
C81.1 Nodular sclerosis	0.004	0.995	0.000
C83.7 Burkitt's tumour	0.004	0.995	0.000
F33.9 Recurrent depressive disorder, unspecified	0.005	0.995	0.000
E61 Deficiency of other nutrient elements	0.000	0.995	0.004
S02.31 Fracture of orbital floor (open)	0.000	0.995	0.004
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.004	0.996	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.004	0.996	0.000
S02.51 Fracture of tooth (open)	0.000	0.996	0.004
A63.0 Anogenital (venereal) warts	0.000	0.996	0.004
F33.4 Recurrent depressive disorder, currently in remission	0.004	0.996	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.004	0.996	0.000
F33.8 Other recurrent depressive disorders	0.004	0.996	0.000
C84.5 Other and unspecified T-cell lymphomas	0.004	0.996	0.000
D68.0 Von Willebrand's disease	0.000	0.996	0.004
S02.01 Fracture of vault of skull (open)	0.000	0.996	0.004
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.004	0.996	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.004	0.996	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.004	0.996	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.004	0.996	0.000
C84.3 Lymphoepithelioid lymphoma	0.004	0.996	0.000
C84.2 T-zone lymphoma	0.004	0.996	0.000
C84.1 Sezary's diease	0.004	0.996	0.000
C91.5 Adult T-cell leukaemia	0.004	0.996	0.000
O32.1 Maternal care for breech presentation	0.004	0.996	0.000
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.000	0.996	0.004
F33.1 Recurrent depressive disorder, current episode moderate	0.004	0.996	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
C94 Other leukaemias of specified cell type	0.004	0.996	0.000
D68.4 Acquired coagulation factor deficiency	0.000	0.996	0.004
R04.0 Epistaxis	0.004	0.996	0.000
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.000	0.996	0.004
C86 Other specified types of T/NK-cell lymphoma	0.004	0.996	0.000
S02.60 Fracture of mandible (closed)	0.000	0.996	0.004
L05 Pilonidal cyst	0.004	0.996	0.000
S02.61 Fracture of mandible (open)	0.000	0.996	0.004
I61.9 Intracerebral haemorrhage, unspecified	0.000	0.996	0.004
R73.0 Abnormal glucose tolerance test	0.000	0.996	0.004
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.004	0.996	0.000
M18 Arthrosis of first carpometacarpal joint	0.000	0.996	0.004
C93 Monocytic leukaemia	0.004	0.996	0.000
S02.71 Multiple fractures involving skull and facial bones (open)	0.000	0.996	0.003
S02.70 Multiple fractures involving skull and facial bones (closed)	0.000	0.996	0.004
Z50.8 Care involving use of rehabilitation procedures	0.000	0.996	0.004
M18.1 Other primary arthrosis of first carpometacarpal joint	0.000	0.996	0.004
C95 Leukaemia of unspecified cell type	0.004	0.996	0.000
I24.1 Dressler's syndrome	0.000	0.996	0.004
Z50 Care involving use of rehabilitation procedures	0.000	0.996	0.004
E61.2 Magnesium deficiency	0.000	0.996	0.003
C91.8 Mature B-cell leukaemia Burkitt-type	0.003	0.996	0.000
C91.7 Other lymphoid leukaemia	0.003	0.996	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.003	0.996	0.000
C91.3 Prolymphocytic leukaemia	0.003	0.996	0.000
C91.2 Subacute lymphocytic leukaemia	0.003	0.996	0.000
D68.1 Hereditary factor XI deficiency	0.000	0.996	0.003
C88 Malignant immunoproliferative diseases	0.003	0.996	0.000
C91.9 Lymphoid leukaemia, unspecified	0.003	0.996	0.000
D68.5 Primary Thrombophilia	0.000	0.996	0.003
E61.9 Deficiency of nutrient element, unspecified	0.000	0.996	0.003
E61.8 Deficiency of other specified nutrient elements	0.000	0.996	0.003
E61.7 Deficiency of multiple nutrient elements	0.000	0.996	0.003
E61.6 Vanadium deficiency	0.000	0.996	0.003
E61.5 Molybdenum deficiency	0.000	0.996	0.003
E61.4 Chromium deficiency	0.000	0.996	0.003
E61.3 Manganese deficiency	0.000	0.996	0.003
E61.0 Copper deficiency	0.000	0.996	0.003
R40.2 Coma, unspecified	0.000	0.996	0.004
Z50.4 Psychotherapy, not elsewhere classified	0.000	0.996	0.003
Z93.2 Ileostomy status	0.004	0.996	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.003	0.997	0.000
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.000	0.997	0.003
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.003	0.997	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
R73.9 Hyperglycaemia, unspecified	0.000	0.997	0.003
K09.0 Developmental odontogenic cysts	0.000	0.997	0.003
F32.2 Severe depressive episode without psychotic symptoms	0.003	0.997	0.000
N75.0 Cyst of Bartholin's gland	0.003	0.997	0.000
C91.4 Hairy-cell leukaemia	0.003	0.997	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.003	0.997	0.000
S02.4 Fracture of malar and maxillary bones	0.000	0.997	0.003
S02.2 Fracture of nasal bones	0.000	0.997	0.003
C94.7 Other specified leukaemias	0.003	0.997	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.003	0.997	0.000
C94.5 Acute myelofibrosis	0.003	0.997	0.000
C94.4 Acute panmyelosis	0.003	0.997	0.000
C94.3 Mast cell leukaemia	0.003	0.997	0.000
C94.2 Acute megakaryoblastic leukaemia	0.003	0.997	0.000
C94.1 Chronic erythraemia	0.003	0.997	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.003	0.997	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.003	0.997	0.000
C96.8 Histiocytic sarcoma	0.003	0.997	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.003	0.997	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.003	0.997	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.003	0.997	0.000
C96.3 True histiocytic lymphoma	0.003	0.997	0.000
C96.2 Malignant mast cell tumour	0.003	0.997	0.000
C96.1 Malignant histiocytosis	0.003	0.997	0.000
C96.0 Letterer-Siwe disease	0.003	0.997	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.000	0.997	0.003
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.003	0.997	0.000
C86.4 Blastic NK-cell lymphoma	0.003	0.997	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.003	0.997	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.003	0.997	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.003	0.997	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.003	0.997	0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.000	0.997	0.003
C85.0 Lymphosarcoma	0.003	0.997	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.003	0.997	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.000	0.997	0.003
M18.5 Other secondary arthrosis of first carpometacarpal joint	0.000	0.997	0.003
M18.4 Other secondary arthrosis of first carpometacarpal joints, bilateral	0.000	0.997	0.003
M18.3 Other posttraumatic arthrosis of first carpometacarpal joint	0.000	0.997	0.003
M18.2 Posttraumatic arthrosis of first carpometacarpal joints, bilateral	0.000	0.997	0.003
I61 Intracerebral haemorrhage	0.000	0.997	0.003
C93.9 Monocytic leukaemia, unspecified	0.003	0.997	0.000
C93.7 Other monocytic leukaemia	0.003	0.997	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.003	0.997	0.000
C93.2 Subacute monocytic leukaemia	0.003	0.997	0.000
C93.0 Acute monocytic leukaemia	0.003	0.997	0.000
H11.3 Conjunctival haemorrhage	0.003	0.997	0.000
C95.7 Other leukaemia of unspecified cell type	0.003	0.997	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.003	0.997	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.003	0.997	0.000
C95.0 Acute leukaemia of unspecified cell type	0.003	0.997	0.000
R73 Elevated blood glucose level	0.000	0.997	0.003
C90.2 Plasmacytoma, extramedullary	0.003	0.997	0.000
H80.9 Otosclerosis, unspecified	0.000	0.997	0.003
Z50.6 Orthoptic training	0.000	0.997	0.003
Z50.3 Drug rehabilitation	0.000	0.997	0.003
C86.5 Angioimmunoblastic T-cell lymphoma	0.003	0.997	0.000
O47 False labour	0.003	0.997	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.003	0.997	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.003	0.997	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.003	0.997	0.000
C88.7 Other malignant immunoproliferative diseases	0.003	0.997	0.000
C88.3 Immunoproliferative small intestinal disease	0.003	0.997	0.000
C88.2 Gamma heavy chain disease	0.003	0.997	0.000
C88.1 Alpha heavy chain disease	0.003	0.997	0.000
M77.12 Lateral epicondylitis (Upper arm)	0.003	0.997	0.000
Z50.5 Speech therapy	0.000	0.997	0.003
C82.3 Follicular lymphoma grade IIIa	0.003	0.997	0.000
I86.1 Scrotal varices	0.003	0.997	0.000
C82.4 Follicular lymphoma grade IIIb	0.003	0.997	0.000
C90.3 Solitary plasmacytoma	0.003	0.997	0.000
C93.1 Chronic monocytic leukaemia	0.002	0.997	0.000
O47.0 False labour before 37 completed weeks of gestation	0.003	0.997	0.000
C82.6 Cutaneous follicle centre lymphoma	0.003	0.997	0.000
C82.5 Diffuse follicle centre lymphoma	0.003	0.997	0.000
F32.8 Other depressive episodes	0.003	0.997	0.000
H71 Cholesteatoma of middle ear	0.000	0.997	0.003
C85.1 B-cell lymphoma, unspecified	0.003	0.997	0.000
F32 Depressive episode	0.003	0.997	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.003	0.997	0.000
C82.2 Large cell, follicular	0.002	0.997	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.997	0.000
C90.1 Plasma cell leukaemia	0.002	0.997	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.000	0.997	0.002
C95.9 Leukaemia, unspecified	0.002	0.997	0.000
I72.3 Aneurysm of iliac artery	0.003	0.997	0.000
L08 Other local infections of skin and subcutaneous tissue	0.003	0.997	0.000
S02.21 Fracture of nasal bones (open)	0.000	0.997	0.002
F30-F39 Mood [affective] disorders	0.003	0.997	0.000
Y83.4 Other reconstructive surgery	0.000	0.997	0.003
K09.2 Other cysts of jaw	0.000	0.997	0.002
L05.0 Pilonidal cyst with abscess	0.002	0.997	0.000
C82.0 Small cleaved cell, follicular	0.002	0.998	0.000
R40.0 Somnolence	0.000	0.998	0.002
F29 Unspecified nonorganic psychosis	0.002	0.998	0.000
I61.8 Other intracerebral haemorrhage	0.000	0.998	0.002
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.000	0.998	0.002
A63 Other predominantly sexually transmitted diseases, not elsewhere classified	0.000	0.998	0.002
K09 Cysts of oral region, not elsewhere classified	0.000	0.998	0.002
R40 Somnolence, stupor and coma	0.000	0.998	0.002
C88.0 Waldenstrom's macroglobulinaemia	0.002	0.998	0.000
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.002	0.998	0.000
W25.9 Unspecified place	0.000	0.998	0.002
Z50.2 Alcohol rehabilitation	0.000	0.998	0.002
I61.3 Intracerebral haemorrhage in brain stem	0.000	0.998	0.002
K62.2 Anal prolapse	0.002	0.998	0.000
F31.8 Other bipolar affective disorders	0.002	0.998	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.000	0.998	0.002
H11 Other disorders of conjunctiva	0.002	0.998	0.000
C91.1 Chronic lymphocytic leukaemia	0.002	0.998	0.000
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.000	0.998	0.002
F38 Other mood [affective] disorders	0.002	0.998	0.000
E10.9 Without complications	0.000	0.998	0.002
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.000	0.998	0.002
K09.1 Developmental (nonodontogenic) cysts of oral region	0.000	0.998	0.002
Z84.8 Family history of other specified conditions	0.002	0.998	0.000
F28 Other nonorganic psychotic disorders	0.002	0.998	0.000
F24 Induced delusional disorder	0.002	0.998	0.000
F21 Schizotypal disorder	0.002	0.998	0.000
K81.0 Acute cholecystitis	0.002	0.998	0.000
F23 Acute and transient psychotic disorders	0.002	0.998	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.000	0.998	0.002
I72.8 Aneurysm of other specified arteries	0.002	0.998	0.000
L08.1 Erythrasma	0.002	0.998	0.000
F31 Bipolar affective disorder	0.002	0.998	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.002	0.998	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.000	0.998	0.002
J86.9 Pyothorax without fistula	0.000	0.998	0.002
R40.1 Stupor	0.000	0.998	0.002
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.002	0.998	0.000
K09.9 Cyst of oral region, unspecified	0.000	0.998	0.002
E78.9 Disorder of lipoprotein metabolism, unspecified	0.002	0.998	0.000
A63.8 Other specified predominantly sexually transmitted diseases	0.000	0.998	0.002
L03.2 Cellulitis of face	0.000	0.998	0.002
L08.0 Pyoderma	0.002	0.998	0.000
C50.3 Lower-inner quadrant of breast	0.000	0.998	0.002
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.002	0.998	0.000
F38.0 Other single mood [affective] disorders	0.002	0.998	0.000
L92.0 Granuloma annulare	0.000	0.998	0.002
O41.0 Oligohydramnios	0.002	0.998	0.000
C92 Myeloid leukaemia	0.002	0.998	0.000
E10.6 With other specified complications	0.000	0.998	0.002
S50.0 Contusion of elbow	0.002	0.998	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.002	0.998	0.000
E10.3 With ophthalmic complications	0.000	0.998	0.002
Z50.1 Other physical therapy	0.000	0.998	0.002
H11.8 Other specified disorders of conjunctiva	0.002	0.998	0.000
J98.0 Diseases of bronchus, not elsewhere classified	0.000	0.998	0.002
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.002	0.998	0.000
F34 Persistent mood [affective] disorders	0.002	0.998	0.000
H11.2 Conjunctival scars	0.002	0.998	0.000
Z71.3 Dietary counselling and surveillance	0.002	0.998	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
F38.8 Other specified mood [affective] disorders	0.002	0.998	0.000
F38.1 Other recurrent mood [affective] disorders	0.002	0.998	0.000
K09.8 Other cysts of oral region, not elsewhere classified	0.000	0.998	0.002
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.000	0.998	0.002
E10 Insulin-dependent diabetes mellitus	0.000	0.998	0.002
L05.9 Pilonidal cyst without abscess	0.002	0.998	0.000
K52.8 Other specified non-infective gastro-enteritis and colitis	0.002	0.998	0.000
Z50.0 Cardiac rehabilitation	0.000	0.998	0.002
F23.8 Other acute and transient psychotic disorders	0.002	0.998	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.002	0.998	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.002	0.998	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.002	0.998	0.000
C76.3 Pelvis	0.002	0.998	0.000
O47.1 False labour at or after 37 completed weeks of gestation	0.002	0.998	0.000
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.000	0.998	0.002
E10.8 With unspecified complications	0.000	0.998	0.002
M67.47 Ganglion, ankle and foot	0.002	0.998	0.000
M67.43 Ganglion, wrist	0.002	0.998	0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.998	0.001
F31.9 Bipolar affective disorder, unspecified	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations